DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
de Gramont A. et al.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Lancet Oncol 2012;
13: 1225-1233
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.